Featured Research

from universities, journals, and other organizations

Possible Exposure To Nerve Agents And Brain Cancer Deaths In Gulf War Veterans

Date:
July 26, 2005
Source:
The National Academies
Summary:
A new research paper to be published in the August 2005 issue of the American Journal of Public Health finds that Gulf War veterans who may have been exposed to nerve agents during the March 1991 weapons demolitions in Khamisiyah, Iraq, appear to have a higher risk for brain cancer death than veterans who were not exposed.

A new research paper to be published in the August 2005 issue of the American Journal of Public Health finds that Gulf War veterans who may have been exposed to nerve agents during the March 1991 weapons demolitions in Khamisiyah, Iraq, appear to have a higher risk for brain cancer death than veterans who were not exposed.

Researchers compared the causes of death in a group of 100,487 possibly exposed U.S. Army Gulf War veterans with those among 224,980 Army Gulf War veterans who were not exposed to nerve agents released during the demolitions and found no difference in overall mortality or all cancer mortality.

However, exposed veterans were about twice as likely to have died from brain cancer as unexposed veterans, corresponding to roughly 12 excess deaths due to brain cancer among the 100,487 exposed veterans over a 9-year period.

The study's authors said additional research is needed to confirm their findings of a higher brain cancer death risk for some Gulf War veterans.

[From: "Mortality in US Army Gulf War Veterans Exposed to 1991 Khamisiyah Chemicals Munitions Destruction."]


Story Source:

The above story is based on materials provided by The National Academies. Note: Materials may be edited for content and length.


Cite This Page:

The National Academies. "Possible Exposure To Nerve Agents And Brain Cancer Deaths In Gulf War Veterans." ScienceDaily. ScienceDaily, 26 July 2005. <www.sciencedaily.com/releases/2005/07/050725182718.htm>.
The National Academies. (2005, July 26). Possible Exposure To Nerve Agents And Brain Cancer Deaths In Gulf War Veterans. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2005/07/050725182718.htm
The National Academies. "Possible Exposure To Nerve Agents And Brain Cancer Deaths In Gulf War Veterans." ScienceDaily. www.sciencedaily.com/releases/2005/07/050725182718.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins